ACTRN12624000520538尚未招募Unknown
Screening for cardiac amyloidosis in patients with newly identified conduction disease
Box Hill Hospital0 个研究点目标入组 220 人开始时间: 2024年4月26日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 65 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients 65 or older who have new conduction disease requiring the implantation of a pacemaker.
排除标准
- •–Known cardiac amyloidosis.
- •–Patients with a clear alternative cause of conduction disease including other infiltrative cardiomyopathies, ischaemia or medication induced conduction disease.
- •–Patients with life expectancy < 12 months or severe comorbidities where screening would not be beneficial for the individual.
研究者
相似试验
招募中
不适用
Screening for Amyloidosis Before Aortic Valve Elective ReplacementE85.9I35.0Amyloidosis, unspecifiedAortic (valve) stenosisDRKS00025236Charité - Universitätsmedizin Berlin1,000
撤回
不适用
Detection of cardiac amyloidosis with 18F-florbetaben PET: a proof-of-principle studyCardiac amyloidosis1002859310011305NL-OMON41377Academisch Medisch Centrum20
Unknown
不适用
Cardiac Amyloidosis : Diagnostic Using Red Flag SignalsCardiac AmyloidosisNCT04459169University Hospital Center of Martinique424
招募中
不适用
Detection of amyloidosis in multiple myeloma patients by [18F]Florbetaben PETNeoplasmsKCT0003186lsan Univeristy Hospital18
尚未招募
Unknown
Screening Patients with Potential Atrial Fibrillation(AF) and Investigating Behavior Change Using IoTAtrial FibrillationJPRN-UMIN000048501Oita University800